Article
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of…
medRxiv · 2023 · Chen, L.; Xu, G.; Song, X.; Zhang, L.; Chen, C.; Xiang, G.; Wang, S.; Zhang, Z.; Wu, F.; Yang, X.; Zhang, L.; Ma, X.; Yu, J.
Key facts
| Title | A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation. |
|---|---|
| First author | Chen, L.; Xu, G.; Song, X.; Zhang, L.; Chen, C.; Xiang, G.; Wang, S.; Zhang, Z.; Wu, F.; Yang, X.; Zhang, L.; Ma, X.; Yu, J. |
| Journal | medRxiv |
| Published | Nov 17, 2023 |
| DOI | 10.1101/2023.11.15.567291 |
| Devices mentioned | K810863, K912666, K954191, K973350, K982485, K990827 |
| Product codes mentioned | DBM, JLX, KQP, LFZ, LIQ, MVW, MZF, NSU, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1